26 records, the earliest from 21 Aug 2020. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.
26 shown.
Sign in to see more, or upgrade your plan to see the full history. Sign in
| Date | Purpose | Notes |
|---|---|---|
| 18 Jul 2026 | Financial Results | Rossari Biotech Ltd has informed NSE that the meeting of the Board of Directors of the Company is scheduled on 18/07/2026,inter alia, to consider and approve Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2026. |
| 27 Apr 2026 | Financial Results/Dividend | Rossari Biotech Limited has informed NSE that the meeting of Board of Directors of the Company is scheduled on 27/04/2026, inter alia, to consider and approve, 1. Audited Financial Statements and Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2026. 2. recommend payment of Final Dividend, if any, for the Financial Year ended March 31, 2026. |
| 17 Jan 2026 | Financial Results | ROSSARI BIOTECH LIMITED has informed the NSE about Board Meeting to be held on January 17, 2026, to inter-alia, to consider and approve the Unaudited Financial results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2025. |
| 15 Oct 2025 | Financial Results | ROSSARI BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 15th October 2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the quarter and half year ended September 30, 2025. |
| 19 Jul 2025 | Financial Results | Rossari Biotech Ltd has informed NSE that the meeting of the Board of Directors of the Company is scheduled on 19/07/2025,inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2025. |
| 25 Apr 2025 | Financial Results/Dividend | Rossari Biotech Ltd has informed NSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2025,inter alia, to consider and approve1. Audited Financial Statements and Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2025.2. recommend payment of Final Dividend, if any, for the Financial Year ended March 31, 2025. |
| 21 Jan 2025 | Financial Results | Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31, 2024. |
| 19 Oct 2024 | Financial Results | To consider and approve the Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2024 |
| 20 Jul 2024 | Financial Results | ROSSARI BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 20-July-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the quarter ended June 30 2024 |
| 29 Apr 2024 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2024 and dividend |
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
